J.L. Fernández-Martínez

Prof. Dr. J.L. Fernández-Martínez

Department of Mathematics, University of Oviedo, Oviedo, Spain
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MHMubasher Hassan
Mubasher Hassan
FAFaryal Mehwish Awan
Faryal Mehwish Awan
ANAnam Naz
Anam Naz
EDEnrique J deAndrés-Galiana
Enrique J deAndrés-Galiana
ÓÁÓscar Álvarez
Óscar Álvarez
Andrzej KloczkowskiAndrzej Kloczkowski
Andrzej Kloczkowski
Big data in health care is a fast-growing field and a new paradigm that is transforming case-based studies to large-scale, data-driven research. As big data is dependent on the advancement of new data standards, technology, and relevant research, the future development of big data applications holds foreseeable promise in the modern day health care revolution. Enormously large, rapidly growing collections of biomedical omics-data (genomics, proteomics, transcriptomics, metabolomics, glycomics, etc.) and clinical data create major challenges and opportunities for their analysis and interpretation and open new computational gateways to address these issues. The design of new robust algorithms that are most suitable to properly analyze this big data by taking into account individual variability in genes has enabled the creation of precision (personalized) medicine. We reviewed and highlighted the significance of big data analytics for personalized medicine and health care by focusing mostly on machine learning perspectives on personalized medicine, genomic data models with respect to personalized medicine, the application of data mining algorithms for personalized medicine as well as the challenges we are facing right now in big data analytics.

1 May 2010 in Journal of Applied Geophysics
Verified
Journal Article
Closed access
JFJ.L. Fernández-Martínez
J.L. Fernández-Martínez
EGEsperanza García-Gonzalo
Esperanza García-Gonzalo
JÁJosé P. Fernández Álvarez
José P. Fernández Álvarez
HKHeidi A. Kuzma
Heidi A. Kuzma
CPCésar O. Menéndez Pérez
César O. Menéndez Pérez

23 December 2010 in IEEE Transactions on Evolutionary Computation
Verified
Journal Article
Closed access
JFJ.L. Fernández-Martínez
J.L. Fernández-Martínez
EGEsperanza García-Gonzalo
Esperanza García-Gonzalo
Particle swarm optimization (PSO) can be interpreted physically as a particular discretization of a stochastic damped mass-spring system. Knowledge of this analogy has been crucial to derive the PSO continuous model and to introduce different PSO family members including the generalized PSO (GPSO) algorithm, which is the generalization of PSO for any time discretization step. In this paper, we present the stochastic analysis of the linear continuous and generalized PSO models for the case of a stochastic center of attraction. Analysis of the GPSO second order trajectories is performed and clarifies the roles of the PSO parameters and that of the cost function through the algorithm execution: while the PSO parameters mainly control the eigenvalues of the dynamical systems involved, the mean trajectory of the center of attraction and its covariance functions with the trajectories and their derivatives (or the trajectories in the near past) act as forcing terms to update first and second order trajectories. The similarity between the oscillation center dynamics observed for different kinds of benchmark functions might explain the PSO success for a broad range of optimization problems. Finally, a comparison between real simulations and the linear continuous PSO and GPSO models is shown. As expected, the GPSO tends to the continuous PSO when time step approaches zero. Both models account fairly well for the dynamics (first and second order moments) observed in real runs. This analysis constitutes so far the most realistic attempt to better understand and approach the real PSO dynamics from a stochastic point of view.

1 June 2012 in Journal of Bioinformatics and Intelligent Control
Verified
Journal Article
Closed access
EGE. García-Gonzalo
E. García-Gonzalo
JFJ.L. Fernández-Martínez
J.L. Fernández-Martínez

21 May 2019 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
ÓÁÓscar Álvarez
Óscar Álvarez
JFJ.L. Fernández-Martínez
J.L. Fernández-Martínez
Introduction: Drug discovery is the process through which potential new compounds are identified by means of biology, chemistry, and pharmacology. Due to the high complexity of genomic data, AI techniques are increasingly needed to help reduce this and aid the adoption of optimal decisions. Phenotypic prediction is of particular use to drug discovery and precision medicine where sets of genes that predict a given phenotype are determined. Phenotypic prediction is an undetermined problem given that the number of monitored genetic probes markedly exceeds the number of collected samples (from patients). This imbalance creates ambiguity in the characterization of the biological pathways that are responsible for disease development. Areas covered: In this paper, the authors present AI methodologies that perform a robust deep sampling of altered genetic pathways to locate new therapeutic targets, assist in drug repurposing and speed up and optimize the drug selection process. Expert opinion: AI is a potential solution to a number of drug discovery problems, though one should, bear in mind that the quality of data predicts the overall quality of the prediction, as in any modeling task in data science. The use of transparent methodologies is crucial, particularly in drug repositioning/repurposing in rare diseases.

1 May 2015 in Journal of Applied Geophysics
Verified
Journal Article
Closed access
JPJLG Pallero
JLG Pallero
JFJ.L. Fernández-Martínez
J.L. Fernández-Martínez
SBS. Bonvalot
S. Bonvalot
OFO. Fudym
O. Fudym